# 2025-23249: FDA's Guide: Recalling That Sketchy Lipstick Fast

2025-23249, Questions and Answers Regarding Mandatory Cosmetics Recalls: Draft Guidance for Industry; Availability, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-12-18, effective Submit either electronic or written comments on the draft guidance by February 17, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-23249
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-23249
- Title: Questions and Answers Regarding Mandatory Cosmetics Recalls: Draft Guidance for Industry; Availability
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 59129
- Published: 2025-12-18
- Effective: Submit either electronic or written comments on the draft guidance by February 17, 2026.
- Comments close: 2026-02-17
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA's Guide: Recalling That Sketchy Lipstick Fast

## Summary

The FDA just dropped a draft guide to help cosmetic companies understand how mandatory recalls work and what to expect if their products need to be pulled from shelves. This guide answers common questions about the recall process, making it easier for businesses to stay safe and compliant. Companies should send their feedback by February 17, 2026, so the FDA can finalize the rules—keeping everyone on track and avoiding costly surprises.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance document entitled "Questions and Answers Regarding Mandatory Cosmetics Recalls: Guidance for Industry." The draft guidance document, when finalized, will provide answers to common questions that might arise about FDA's mandatory recall authority for cosmetics. It is intended to inform regulated industry about the Agency's current thinking on implementation of certain aspects, including the criteria, process, and expectations, for mandatory recalls of cosmetic products.

## Effects PRIA read

- Draft Q&A on Mandatory Cosmetics Recalls: benefit, medium. The FDA released a draft guidance titled "Questions and Answers Regarding Mandatory Cosmetics Recalls" that explains its current thinking on how mandatory cosmetics recalls will work, including the criteria, process, and expectations under section 611 of the FD&C Act (added by section 3502 of MoCRA…
- Guidance Is Nonbinding; Alternatives Allowed: benefit, low. The draft guidance says it does not establish any rights and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations.
- No New Information-Collection Burden: benefit, low. FDA tentatively concluded that the draft guidance contains no collection of information, so Office of Management and Budget clearance under the Paperwork Reduction Act of 1995 is not required. This means the draft guidance does not add new paperwork requirements as written.
- Deadline to Comment on Draft Guidance: benefit, low. If you want FDA to consider your feedback before it begins work on the final guidance, submit electronic or written comments by February 17, 2026. Comments submitted to https://www.regulations.gov will be posted publicly unless submitted as confidential written/paper submissions following FDA instr…
- FDA Will Consider Comments on Costs: benefit, low. As FDA develops final guidance, the Agency will consider comments on costs or cost savings the guidance may generate, which is relevant to Executive Order 14192. Stakeholders can submit such cost-related comments for FDA to review when finalizing the guidance.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-23249 on federalregister.gov](https://www.federalregister.gov/documents/2025/12/18/2025-23249/questions-and-answers-regarding-mandatory-cosmetics-recalls-draft-guidance-for-industry-availability)
- [2025-23249 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-12-18/pdf/2025-23249.pdf)

## Related
- [Previous: 2025-23247, Chromium Trioxide From India and Turkey; Revised Schedule for the Subject Proce…](https://policyrisk.com/federal-register/2025-23247)
- [Next: 2025-23251, Submission for OMB Review; 30-Day Comment Request; Special Volunteer and Guest…](https://policyrisk.com/federal-register/2025-23251)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-23249 (as of 2026-06-08).
